United Therapeutics Corporation (NASDAQ: UTHR) Q1 2026 Earnings Call Transcript May 6, 2026 United Therapeutics Corporation ...
Enter e-mail address Are you an IOP member? Create a Physics World account to get access to all available digital issues of ...
Zacks Small Cap Research on MSN
RVPH: Shareholder letter introduces new IP
By John Vandermosten, CFA NASDAQ: RVPH On behalf of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH), Chief Executive Officer, Dr. Laxminarayan Bhat, composed a letter to shareholders ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A wrapped Tesla Model Y. Photo: Christophe Gateau/dpa (Photo by Christophe Gateau/picture ...
Tesla is producing a final limited-edition “Signature Series” run of the Plaid Model S and Model X — 350 vehicles total — as a farewell to its flagship programs before they shut down for good. The ...
Tesla Model Q or Model 2 Affordable SUV Comes Back Rolling to the Rumor Mill, Here's a New Rendering
Tesla, even though it’s not the world’s largest EV automaker – it was surpassed last year by China’s BYD – always remains on top when it comes to both good and bad news. For example, in April alone, ...
One of life’s abiding mysteries—at least to this writer—has been Tesla’s enduring success over recent years despite offering so few choices for customers. With the death of the low-volume and ...
In the wake of Anthropic’s announcement of its latest artificial intelligence model, Mythos, on April 7, the company has stood by an unusual decision: refusing to release it to the public. Not since ...
Anthropic announced that it has started a very limited test of its newest AI model called Mythos. It's a model deemed so powerful that the company warned it could cause widespread disruption if it ...
From her first fashion shoot with Vogue in 1976 to Mugler runways, and founding Iman Cosmetics, Iman is the original supermodel we read about in our history books. Born in Somalia as Zara Mohamed ...
Munich, Germany, April 23, 2026 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stage company developing small molecule medicines for inflammatory and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results